Clin2
NCT07081503Possibly a fitRecruiting

Testing ADX-626 in healthy adults

Healthy Adult Participants

This study tests a new investigational drug called ADX-626 in healthy volunteers for the first time in humans. The goal is to see how the drug is processed by the body and whether it is safe, helping to decide if it can be studied in future patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
44 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are between 18 and 45 years old.
  • You are a man or a woman who cannot become pregnant (e.g., surgically sterile or past menopause).
  • You weigh at least 110 pounds (50 kg) and have a body mass index (BMI) of 25 or less.
  • You are generally healthy — no major medical conditions like high blood pressure, diabetes, heart disease, or cancer.
  • You do not have a bleeding disorder and have not had serious bleeding in the past.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07352423Recruiting· Phase 1
Safety study of ALXN2230 in healthy volunteers

This trial tests the safety and how the body handles a new drug called ALXN2230 in healthy people. It helps find the right dose and checks for side effects.

London
NCT07729839Recruiting· Phase 1
Study of ADB116 injection for healthy volunteers

This trial tests a new medicine called ADB116 in healthy people to see how safe it is and how the body processes it. The results will help decide the right dose for future studies.

Guangzhou, Guangdong
NCT07065136Not yet recruiting· Phase 1
Safety study of 627 in healthy adults

This trial tests a new medication called 627 in healthy adults to see how safe it is and how the body processes it. It's a first-in-human study, so the main goal is to make sure the drug is well-tolerated.

NCT07713485Recruiting· Phase 1
XmAb412 study in healthy adults

This is a first-in-human study testing a new drug called XmAb412 in healthy volunteers. It helps researchers understand how the drug works in the body and if it's safe.

Joondalup, Western Australia
NCT07757659Not yet recruiting· Phase 1
Study of a new drug in healthy adults

This trial studies a new drug called XKH001 in healthy volunteers. It is a single-dose study to see how the drug is processed by the body and to check for safety and tolerability.

Melbourne
NCT07444385Recruiting· Phase 1
Safety study of two new drugs in healthy men

This study tests two new experimental drugs (AD-116 and AD-1161) in healthy adult men to see how safe they are and how the body processes them. If you are a healthy man who meets the weight and age criteria, you may be able to join.

Seoul

Hear when a new Healthy Adult Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.